Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.

@article{Khellaf2005AssessmentOA,
  title={Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.},
  author={Mehdi Khellaf and Marc Michel and Annette Schaeffer and Philippe Bierling and Bertrand Godeau},
  journal={Haematologica},
  year={2005},
  volume={90 6},
  pages={
          829-32
        }
}
BACKGROUND AND OBJECTIVES The optimal treatment for patients with autoimmune thrombocytopenic purpura (AITP) and a platelet count < or =20x10(9)/L is intravenous immunoglobulin (IVIg) but this treatment is expensive and steroids are a good alternative in less severe cases. Since the occurrence of life-threatening hemorrhage in adult AITP is a rare event, the aim of our study was to validate a therapeutic strategy based on a bleeding score for the short-term management of adults with AITP and a… CONTINUE READING

Figures, Tables, and Topics from this paper.

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 46 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults , children and in pregnancy

E Schattner, J Bussel
  • 2003

Immune thrombocytopenic purpura.

  • The New England journal of medicine
  • 2002
VIEW 1 EXCERPT